SBN 0.00% 0.0¢ sun biomedical limited

Nanotechnology integrated into such devices comes at a cost. The...

  1. 1,017 Posts.
    Nanotechnology integrated into such devices comes at a cost. The base cost of the actual electronic cradle device is very expensive and has been designed for low spread distribution single point test model scenarios ie roadside, diagnostics, hospitals and test laboratories etc. Unless production and development costs fall dramatically, nanotechnology is unlikely to find a place in the more generic testing regimes of the workplace, entertainment and school testing programs that incidentally, represent the primary targets for SBN.

    Cheers
 
watchlist Created with Sketch. Add SBN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.